Gene: ZNF140
Official Full Name: zinc finger protein 140provided by HGNC
Gene Summary: Enables DNA-binding transcription repressor activity, RNA polymerase II-specific and sequence-specific double-stranded DNA binding activity. Involved in negative regulation of transcription by RNA polymerase II. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO34589 | ZNF140 Knockout cell line (HeLa) | Human | ZNF140 | 1:3~1:6 | Negative | Online Inquiry |
KO34590 | ZNF140 Knockout cell line (HEK293) | Human | ZNF140 | 1:3~1:6 | Negative | Online Inquiry |
KO34591 | ZNF140 Knockout cell line (A549) | Human | ZNF140 | 1:3~1:4 | Negative | Online Inquiry |
ZNF140 Gene Knockout Cell Lines are specialized cellular systems developed to functionally characterize the ZNF140 gene, a member of the zinc-finger protein family known to play significant roles in transcriptional regulation and cellular signaling. These cell lines are engineered through precise gene editing techniques, such as CRISPR-Cas9, to create models that completely lack the ZNF140 gene, thereby allowing researchers to investigate its contributions to various biological processes and disease mechanisms.
The primary function of ZNF140 Gene Knockout Cell Lines lies in their ability to elucidate the gene's role in cellular functions, such as gene expression regulation, cell proliferation, differentiation, and apoptosis. By comparing these knockout cell lines with wild-type counterparts, researchers can study changes in cellular behavior, signaling pathways, and gene expression profiles, providing insights that could have implications in understanding diseases like cancer, metabolic disorders, and neurodegenerative conditions.
The scientific importance of these cell lines extends to their practical applications in both basic research and therapeutic development. For instance, they can serve as valuable tools for drug discovery, enabling researchers to screen potential therapeutics that may either rectify the effects of ZNF140 deficiency or target its downstream pathways. Furthermore, these models can aid in the identification of gene interactions and functional redundancies within the genome, contributing to a better understanding of complex genetic networks.
Compared to alternative models such as overexpressing systems or conventional knockdown approaches using siRNA, ZNF140 Gene Knockout Cell Lines provide a more complete and permanent loss-of-function scenario. This allows for the investigation of compensatory mechanisms that might otherwise mask the effects of transient interventions, thus yielding more reliable data.
For researchers and clinicians who are committed to advancing their understanding of gene function and disease pathology, ZNF140 Gene Knockout Cell Lines offer an invaluable resource that delivers both robustness and specificity. Our company prides itself on its commitment to providing high-quality biological products that are rigorously validated for research applications, enabling the scientific community to push the boundaries of knowledge toward groundbreaking discoveries.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.